Topical bimatoprost for the treatment of eyebrow hypotrichosis

Eric S. Schweiger, Lisa Pinchover, Robert M. Bernstein

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Topical bimatoprost was FDA approved in December of 2008 for the treatment of eyelash hypotrichosis. Since its approval, some physicians have advocated the use of bimatoprost "off label" for hair growth in other areas, such as the scalp or eyebrows, but there has yet to be published scientific evidence to support this use. We report one of the first cases of significant eyebrow hair growth in a patient after use of topical bimatoprost for eyebrow hypotrichosis.

Original languageEnglish
Pages (from-to)106-108
Number of pages3
JournalJournal of Drugs in Dermatology
Volume11
Issue number1
StatePublished - Jan 2012

Fingerprint

Dive into the research topics of 'Topical bimatoprost for the treatment of eyebrow hypotrichosis'. Together they form a unique fingerprint.

Cite this